金币
UID158465
帖子
主题
积分2485
注册时间2014-1-29
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
A new series of General Chapters on the different aspects of the pharmaceutical supply chain ("Good Distribution Practices") which should replace the current chapters on the topic has been published in the Pharmacopoeial Forum 40(1). A review of the current chapters (<1079>, <1083> and <1197>) has shown that the contents partly overlap each other. That's why these GDP chapters should be reorganised from a higher perspective.
The chapters address material flow beginning with initial procurement and continuing throughout the supply chain to delivery to the end user. They apply to APIs, excipients, as well as to medicinal products and medical devices.
The 4 main GDP topics are now organised as follows:
1083.1 Quality Management System
1083.2 Environmental Conditions Management
1083.3 Good Importation and Exportation Practices
1083.4 Suppy Chain Integrity and Security
Supply Chain Integrity and Security (SCIS) is defined as a series of policies, procedures, and technologies which are used to ensure visibility and traceability of products. The ultimate objective is to identify falsified or manipulated products and prevent them from entering the supply chain - and, as a matter of fact - the market. |
|